The US House passed the MORE Act last week, seeking to decriminalize marijuana and remove it as a Schedule I drug under the Controlled Substances Act. The US Senate must also approve the bill before it can be sent to the president who can sign the bill into law or veto it. Should the bill become law, this will present an opportunity for cannabis related companies to sell Cannabis products in the US and to bring their brand and products to the US.
CBD is one of the hottest consumer products in the market today. It’s being added to everything from tea to body lotion and meatballs. Pet products are another possibly lucrative market since people love splurging on their pets. Last year, Americans spent $33 billion on pet food and treats, according to Nielsen.
Dogs and cats are increasingly taking the non-intoxicating cannabis compound as their owners seek to provide relief to their four-legged friends for everything from anxiety to pain and seizures. For example, a recent Cornell University study found that once the right dosage is determined for a pet, CBD can ease pain stemming from arthritis. Dr. Joseph Wakshlag and his colleagues found that more than 80% of the dogs in the study saw a significant decrease in pain and improved mobility.
Sales of CBD pet products quadrupled last year to $32 million from $8 million in 2017, according to the Brightfield Group. The cannabis-focused research firm estimates the market could balloon to $1.16 billion in the U.S. alone by 2022.
Charlotte’s Web (OTC: CWBHF), a pioneer in the CBD oil industry, introduced its first ingestible oil for dogs in 2016. the company recently rolled out a full line of new products for canines, including a chicken-flavored CBD oil, semi-moist meat chews and a balm that’s safe for dogs to lick, among other products.
The company saw the growth estimates for CBD pet products and decided the market will become a “big chunk of business” in the CBD industry, said senior marketing manager Antoine Awwad. It also found many people who first buy CBD for their pets later buy some for themselves, he said. Schaus said she and her Australian Shepherd both use it now.
In Q4 of 2018, the company’s revenues from animal nutrition products grew by 126%.
LinkResPet (OTC: LRSV), a UK based CBD provider, is here to help solve these health issues the natural way, through specialised cannabidiol (CBD) products made specifically for pets.
Last week, the company announced that it is current with all of its OTC Market filings and has achieved “Current Information” status, with no risk or yields signs associated with the stock on OTCMarkets.com.
“I am delighted that the Company is current once again and we can focus back on the business,” commented Rene Lauritsen, LinkResPet CEO. “We continue to explore the potential for growth in the CBD and wellness market and are currently assessing a number of avenues through which we can expand our presence, including further developing our product range,” he added.
The Company has updated all financial reports and disclosure statements and will resume operations with its LinkResPet brand, making further announcements as new developments arise.
The Company also recently raised its Authorized Shares in order to issue shares to its CEO, Rene Lauritsen, for an acquisition that is pending which he initiated. These newly issued shares are restricted for one year per Rule 144 and if the acquisition is not completed the shares will be returned to treasury. As shareholders may note, LRSV’s share structure had previously been unchanged for almost four years.
Perceiving the market opportunities, and, more importantly, the growing pet owners’ needs for natural therapies, LinkResPet launched a line of CBD products especially tailored for cats, dogs and horses. Designed to for easy absorption and administration, LinkResPet products come in tincture form and are made of hemp-derived CBD isolates, which are non-toxic, all natural, THC and GMO free. While the CBD products are meant to tackle a variety of issues aforementioned, there is also an emphasis in promoting homeostasis in the body and improving the animal’s overall wellness.
CBD Life Sciences (OTC: CBDL) through its wholly owned subsidiary, LBC Bioscience Inc. President & CEO, Lisa Nelson announced last week a Letter of Understanding on leasing a Hemp Farm in Arizona.
The Company previously announced leasing a hemp farm here in Arizona and the company expects to finalize this agreement within the next week. Lisa Nelson states “This will give the company more revenue, exposure, & overall more production within our product line. It is wonderful news to the customers, and this is going to bring growth to the table at full capacity”.
Hemp is an infinite versatile crop. From paper to biodiesel fuel to wellness-promoting oil, hemp can be turned into an almost endless supply of different products. In fact, there are over 25,000 different uses for hemp, including food, building supplies, textiles, skincare products, oils, and more. Every part of a hemp plant can be used in some way, shape, or fashion.
LBC Bioscience Inc. is well stocked already as it is with some very high-quality CBD offerings – all at very reasonable prices with its Holiday Specials. Check out LBC Bioscience Inc’s newest product offerings including its: 100mg CBD Bath Bombs in a variety of scents with Holiday Scents coming within the next week. 1500 MG Premium Berry Drops, 100MG CBD Tablets and our tasty CBD Gumballs. Or shop our top selling products (based on order frequency) which include our CBD Pain Cream, CBD Oils and CBD Pet Treats.
CBD of Denver, Inc. (OTC: CBDD), a full-line CBD and Hemp oil company (“CBDD”) selling Black Pearl CBD hemp products and a producer and distributor of CBD products in Switzerland, announced last week that the company is in negotiations with a Swiss chain store to supply CBD products.
Rockflowr Exchange made their first sale of CBD products to Switzerland’s Spar Retail outlets last week. Spar has retail grocery outlets throughout Switzerland, signaling what could be the beginning of the mainstreaming of the Rockflowr brand and CBD products in Switzerland.
“We are very excited about the news that the US House passed the MORE Act to decriminalize and deschedule marijuana and look forward to the federal legalization of marijuana. When marijuana becomes legal on the federal level, we will look into selling both CBD and marijuana related products in the US. We are also very pleased with our negotiations with Spar, we have been working on this project for quite some time,” stated CBDD CEO Marcel Gamma.
CBDD is focused on using equity to acquire profitable Swiss assets at attractive valuations to create value for all shareholders.
The company offers a superior CBD product that is full spectrum without depending on THC to activate the benefits of cannabidiol and just received word that their new ecommerce website will be operational by the end of this and can be found at www.blackpearlcbd.com.